1. China Stocks

  2. •

    Technology services

  3. •

    Packaged software
Genimous Technology Co., Ltd. Class A

Genimous Technology Co., Ltd. Class A

SSZSE:000676
6.39
CNY
+0.30
(+4.93%)
0.19EPS
31.44P/E
6.44BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.08
0.91
0.77
2.62
5.08
6.11
8.66
8.5
4.58
2.14
2.31
2.7
3.29
3.38
Basic EPS, GAAP
0.05
-0.17
0.01
0.35
0.42
0.57
0.49
-2.3
0.11
-0.29
0.25
0.17
0.11
0.16
Free Cash Flow per Basic Share
0.05
0.15
0.07
0.01
-0.05
0.22
0.09
-0.18
0.06
0.6
-0.21
0.01
-0.08
- -
Dividend per Share
0.05
0.05
0.03
- -
0.01
0.04
0.03
0.05
0.02
0.01
- -
- -
- -
0.01
Book Value per Share
0.51
0.35
0.35
3.67
4.02
4.67
5.03
2.79
3.01
2.81
3.08
3.29
3.39
3.42
Tangible Book Value per Share
0.4
0.23
0.33
1.29
1.77
2.37
2.86
2.25
2.4
2.47
2.74
2.99
3.11
3.15
Basic Weighted Avg Shares
409
409
410
903
1,256
1,255
1,255
1,268
1,276
1,276
1,268
1,257
1,253
1,253
Sales/Revenue/Turnover
440
373
318
2,364
6,375
7,674
10,874
10,778
5,844
2,729
2,929
3,390
4,119
4,239
Operating Margin (%)
4.52
-7.19
-11.11
12.38
8.18
10.45
4.67
-1
5.61
8.79
7.38
7.75
7.1
6.72
Depreciation Expense
20
20
16
33
67
58
58
56
48
37
32
27
27
- -
Net Income, GAAP
21
-69
4
316
527
713
620
-2,916
135
-368
322
213
142
204
Effective Tax Rate (%)
27.07
- -
- -
12.64
3.75
7.92
8.53
- -
- -
- -
2.34
- -
- -
3.73
Profit Margin (%)
4.78
-18.38
1.1
13.37
8.27
9.3
5.7
-27.06
2.32
-13.49
11
6.27
3.44
4.8
Working Capital
-21
-90
43
2,160
2,421
2,425
2,456
2,033
1,870
1,999
2,369
2,740
2,895
2,963
LT Debt
16
15
1
1
98
- -
- -
200
27
9
24
15
4
8
Total Equity
232
150
146
4,610
5,055
5,863
6,655
3,668
3,802
3,561
3,991
4,292
4,453
4,480
Return on Invested Capital (%)
-3.74
- -
- -
11.94
10.06
11.71
8.83
- -
- -
- -
11.21
- -
- -
5.26
Return on Capital (%)
8.01
- -
- -
12.71
10.52
12.13
9.56
- -
- -
- -
6.31
- -
- -
3.76
Return on Common Equity (%)
10.98
-38.91
2.44
13.3
10.92
13.07
9.89
-56.24
3.59
-9.91
8.57
5.25
3.36
4.79

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
334
361
319
LT Borrowings
- -
- -
- -
LT Finance Leases
4
- -
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,260
1,260
1,260
Market Capitalization
10,872
9,574
6,438

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,592
3,577
3,668
Cash, Cash Equivalents & STI
1,537
1,509
1,611
Accounts Receivable, Net
1,159
1,172
1,170
Inventories
19
24
22
Total Current Liabilities
697
657
705
Payables & Accruals
- -
- -
- -
ST Debt
334
361
319
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
308.12%
4.14%
3.77%
Free Cash Flow
-206.56%
-32.3%
-643.64%
Net Income, GAAP
770.94%
-146.34%
-33.42%
Sales/Revenue/Turnover
82.08%
-10.9%
21.53%
Total Cash Common Dividend
31.38%
-31.18%
17.79%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
755
721
896
1,018
3,390
2025
1,110
1,055
- -
1,012
4,119
2026
1,046
1,127
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.04
0.04
0.05
0.17
2025
0.04
0.03
- -
0.02
0.11
2026
0.04
0.08
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Zhi Feng Chen
Full Time Employees
406
Sector
Technology services
Industry
Packaged software
Address
Room 404, No. 56-3, Guangzhou GD China 510806
IPO Date
Dec 24, 1996
Website
genimous.com
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
Genimous Technology Co., Ltd. engages primarily in the research, development, manufacture, and sale of genetic testing products and services. The company's main product lines include high-throughput genetic sequencing platforms; gene chip technology; whole genome sequencing services; prenatal and reproductive genetic testing; precision medicine solutions; and personalized genetic health risk assessments. Genimous also provides bioinformatics analysis, genetic data interpretation, and consulting services targeted at hospitals, research institutions, and healthcare providers. The company serves a broad geographic market including China, with expanding operations in Asia and emerging global markets. Founded in 2010, Genimous Technology is headquartered in Shenzhen, China. In the past 1-2 years, Genimous Technology has made significant strategic advancements including forging partnerships with leading healthcare and technology firms to enhance its genetic data analytic capabilities and expand its service offerings. The company has introduced new prenatal genetic screening products leveraging advanced AI algorithms for higher accuracy and broader applicability. Additionally, Genimous has engaged in several funding rounds aimed at scaling its production capacity and accelerating research and development activities. These expansions reflect the company's strategic focus on precision medicine and genetic diagnostics growth sectors. There have been no recent name changes or major reorganizations reported, but the company continues to broaden its service portfolio with innovative genetic solutions to maintain competitive edge in the biotechnology industry.